Impact of Non-Surgical Periodontal Treatment on the Concentration and Level of MRP-8/14 (Calprotectin) as an Inflammatory Biomarker in Women with Periodontitis and Rheumatoid Arthritis: A Quasi-Experimental Study
The aim of this study was to evaluate the impact of non-surgical periodontal treatment (NS-PT) on periodontal parameters and inflammatory biomarkers in the concentration and level of calprotectin (CLP) in women with periodontitis and rheumatoid arthritis (RA). In this quasi-experimental study, we evaluated 30 women (mean age: 52.0 ± 5.8 years) with periodontitis and RA who had been diagnosed and treated for RA for more than 3 years and whose activity markers remained at similar values without significant reduction over three consecutive months. Patients underwent NS-PT, which included plaque control, scaling, and root planing. Serum and saliva samples, periodontal indices, RA activity markers, Disease Activity Score-28 (DAS28), the erythrocyte sedimentation rate (ESR), and the C-reactive protein (CRP) and CLP contents were measured at the beginning of the study and 6 and 12 weeks after NS-PT. Parametric and nonparametric tests were used in the analysis. The mean age was 52.0 ± 5.8 years. Compared to the baseline results, all periodontal indices were significantly reduced 6 and 12 weeks after NS-PT (<i<p</i< < 0.001). DAS28 was also significantly reduced after 12 weeks (<i<p</i< < 0.0001). Similarly, the serum CLP concentration decreased 6 and 12 weeks after NS-PT (<i<p</i< < 0.0001). Of the patients, 100% presented lower levels of CRP and ESR (<i<p</i< < 0.0001). Overall, NS-PT reduced inflammation and disease activity, highlighting the importance of oral health in the control and treatment of systemic diseases such as RA and confirming that NS-PT effectively reduces periodontitis activity and plays a key role in modulating RA activity. Therefore, NS-PT should be considered as an adjunct treatment for RA..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
---|---|
Enthalten in: |
Diseases - 12(2024), 1, p 12 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Elena Aurora Popoca-Hernández [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
Inflammatory biomarkers |
---|
doi: |
10.3390/diseases12010012 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ096376562 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ096376562 | ||
003 | DE-627 | ||
005 | 20240413150822.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240413s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/diseases12010012 |2 doi | |
035 | |a (DE-627)DOAJ096376562 | ||
035 | |a (DE-599)DOAJfb5c0f53091f4e1e83d72703a8fc61b9 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a Elena Aurora Popoca-Hernández |e verfasserin |4 aut | |
245 | 1 | 0 | |a Impact of Non-Surgical Periodontal Treatment on the Concentration and Level of MRP-8/14 (Calprotectin) as an Inflammatory Biomarker in Women with Periodontitis and Rheumatoid Arthritis: A Quasi-Experimental Study |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a The aim of this study was to evaluate the impact of non-surgical periodontal treatment (NS-PT) on periodontal parameters and inflammatory biomarkers in the concentration and level of calprotectin (CLP) in women with periodontitis and rheumatoid arthritis (RA). In this quasi-experimental study, we evaluated 30 women (mean age: 52.0 ± 5.8 years) with periodontitis and RA who had been diagnosed and treated for RA for more than 3 years and whose activity markers remained at similar values without significant reduction over three consecutive months. Patients underwent NS-PT, which included plaque control, scaling, and root planing. Serum and saliva samples, periodontal indices, RA activity markers, Disease Activity Score-28 (DAS28), the erythrocyte sedimentation rate (ESR), and the C-reactive protein (CRP) and CLP contents were measured at the beginning of the study and 6 and 12 weeks after NS-PT. Parametric and nonparametric tests were used in the analysis. The mean age was 52.0 ± 5.8 years. Compared to the baseline results, all periodontal indices were significantly reduced 6 and 12 weeks after NS-PT (<i<p</i< < 0.001). DAS28 was also significantly reduced after 12 weeks (<i<p</i< < 0.0001). Similarly, the serum CLP concentration decreased 6 and 12 weeks after NS-PT (<i<p</i< < 0.0001). Of the patients, 100% presented lower levels of CRP and ESR (<i<p</i< < 0.0001). Overall, NS-PT reduced inflammation and disease activity, highlighting the importance of oral health in the control and treatment of systemic diseases such as RA and confirming that NS-PT effectively reduces periodontitis activity and plays a key role in modulating RA activity. Therefore, NS-PT should be considered as an adjunct treatment for RA. | ||
650 | 4 | |a oral health | |
650 | 4 | |a periodontitis | |
650 | 4 | |a periodontal treatment | |
650 | 4 | |a inflammatory biomarkers | |
650 | 4 | |a rheumatoid arthritis | |
653 | 0 | |a Medicine | |
653 | 0 | |a R | |
700 | 0 | |a Rita Elizabeth Martínez-Martínez |e verfasserin |4 aut | |
700 | 0 | |a Roberto Fidencio González-Amaro |e verfasserin |4 aut | |
700 | 0 | |a Perla del Carmen Niño-Moreno |e verfasserin |4 aut | |
700 | 0 | |a José Luis Ayala-Herrera |e verfasserin |4 aut | |
700 | 0 | |a Alberto Vinicio Jerezano-Domínguez |e verfasserin |4 aut | |
700 | 0 | |a Leon Francisco Espinosa-Cristóbal |e verfasserin |4 aut | |
700 | 0 | |a María de Lourdes Márquez-Corona |e verfasserin |4 aut | |
700 | 0 | |a Irene Aurora Espinosa-de Santillana |e verfasserin |4 aut | |
700 | 0 | |a Carlo Eduardo Medina-Solís |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Diseases |d MDPI AG, 2014 |g 12(2024), 1, p 12 |w (DE-627)DOAJ000030473 |x 20799721 |7 nnns |
773 | 1 | 8 | |g volume:12 |g year:2024 |g number:1, p 12 |
856 | 4 | 0 | |u https://doi.org/10.3390/diseases12010012 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/fb5c0f53091f4e1e83d72703a8fc61b9 |z kostenfrei |
856 | 4 | 0 | |u https://www.mdpi.com/2079-9721/12/1/12 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2079-9721 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 12 |j 2024 |e 1, p 12 |